Cardiovascular Systems to Webcast Fiscal 2011 Second-Quarter Earnings Conference Call Wednesday, February 2
January 26 2011 - 12:09PM
Business Wire
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a
live webcast of its fiscal 2011 second-quarter conference call on
Wednesday, February 2, 2011, at 3:45 p.m. CT (4:45 p.m. ET). David
L. Martin, president and chief executive officer, and Laurence L.
Betterley, chief financial officer, will discuss the company’s
results for its fiscal second quarter ended December 31, 2010, and
its financial outlook. The company will issue a post-market
earnings release on February 2.
To access the live webcast, go to the investor information
section of the company’s website, www.csi360.com, on the day of the
conference call and click on the webcast icon. A webcast replay
will be available beginning at 7 p.m. CT the same day.
To participate in the conference call, dial (888) 713-4211 and
enter 43108086. Please dial in at least 10 minutes prior to the
call. To pre-register for the call, log on to the following
website:
https://www.theconferencingservice.com/prereg/key.process?key=PLDGDLM8B.
When joining the call, pre-registered participants can enter their
PIN code, and other participants can press *0 to reach the
operator, or wait on the line for operator assistance.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (888) 286-8010 and
enter access number 51161917. The audio replay will be available
beginning at 8 p.m. CT on Wednesday, February 2, 2011, through 6
p.m. CT on Friday, February 4, 2011.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a
medical device company focused on developing and commercializing
interventional treatment systems for vascular disease. The
company’s Diamondback 360® and Diamondback Predator 360™ PAD
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg in a few minutes of treatment time, and address
many of the limitations associated with existing surgical, catheter
and pharmacological treatment alternatives. As many as 12 million
Americans suffer from peripheral arterial disease (PAD), which is
caused by the accumulation of plaque in peripheral arteries
(commonly the pelvis or leg) reducing blood flow. Symptoms include
leg pain when walking or at rest, and can lead to tissue loss and
eventually limb amputation. In August 2007, the U.S. FDA granted
510(k) clearance for the use of the Diamondback 360° as a therapy
for PAD, and CSI commenced a U.S. product launch in September 2007.
Since then, over 37,000 procedures have been performed using the
Diamondback 360° in leading institutions across the United States.
For more information visit the company’s Web site at
www.csi360.com.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2023 to Jun 2024